Notify me when Logos Global Management LP files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 53 | $1.01B | +$364M | -$281M | +$83.5M | RVMD, IDYA, AKRO, ARVN, OCUL | 13F-HR | 11/14/2025, 02:31 PM |
| Q2 2025 | 45 | $749M | +$353M | -$212M | +$142M | IDYA, AKRO, RVMD, JAZZ, IRON | 13F-HR | 8/14/2025, 09:10 AM |
| Q1 2025 | 39 | $563M | +$240M | -$395M | -$156M | IDYA, RVMD, AKRO, JANX, NUVL | 13F-HR | 5/15/2025, 10:04 AM |
| Q4 2024 | 47 | $855M | +$350M | -$330M | +$19.6M | IDYA, JANX, RVMD, CYTK, VERA | 13F-HR | 2/14/2025, 12:00 PM |
| Q3 2024 | 53 | $893M | +$315M | -$329M | -$14.2M | IDYA, GPCR, RVMD, IRON, JANX | 13F-HR | 11/14/2024, 02:51 PM |
| Q2 2024 | 51 | $868M | $0 | $0 | IDYA, ARGX, MRUS, RVMD, GPCR | New Holdings | 8/27/2024, 05:11 PM | |
| Q2 2024 | 51 | $868M | +$448M | -$429M | +$19M | IDYA, ARGX, MRUS, RVMD, GPCR | 13F-HR | 8/14/2024, 01:38 PM |
| Q1 2024 | 50 | $947M | +$433M | -$433M | -$549K | IDYA, IMCR, IMVT, OCUL, SRPT | 13F-HR | 5/15/2024, 04:10 PM |
| Q4 2023 | 47 | $899M | +$329M | -$319M | +$9.74M | CYTK, IDYA, APLS, ARGX, OLMA | 13F-HR | 2/14/2024, 03:35 PM |
| Q3 2023 | 52 | $701M | +$222M | -$221M | +$1.82M | IMVT, IDYA, OLMA, RCKT, CYTK | 13F-HR | 11/14/2023, 09:25 AM |
| Q2 2023 | 50 | $724M | +$179M | -$263M | -$84M | APLS, CYTK, IMVT, IDYA, SRPT | 13F-HR | 8/14/2023, 09:40 AM |
| Q1 2023 | 43 | $699M | +$145M | -$204M | -$58.8M | APLS, IDYA, CYTK, IMVT, ISEE | 13F-HR | 5/15/2023, 10:19 AM |
| Q4 2022 | 40 | $854M | +$203M | -$178M | +$24.7M | IDYA, APLS, CYTK, IMVT, ALLK | 13F-HR | 2/14/2023, 10:17 AM |
| Q3 2022 | 38 | $801M | +$222M | -$147M | +$74.3M | APLS, CYTK, IDYA, VTYX, DSGN | 13F-HR | 11/14/2022, 01:12 PM |
| Q2 2022 | 32 | $545M | +$146M | -$257M | -$111M | CYTK, APLS, IDYA, DSGN, SRPT | 13F-HR | 8/15/2022, 10:59 AM |
| Q1 2022 | 47 | $771M | +$242M | -$291M | -$49M | CYTK, ALXO, APLS, DSGN, NBIX | 13F-HR | 5/16/2022, 10:50 AM |
| Q4 2021 | 66 | $970M | +$299M | -$500M | -$201M | ALXO, CYTK, DSGN, BCYC, APLS | 13F-HR | 2/14/2022, 05:05 PM |
| Q3 2021 | 57 | $1.38B | +$489M | -$259M | +$231M | ALXO, OLMA, DCPH, BCYC, DYN | 13F-HR | 11/15/2021, 01:44 PM |
| Q2 2021 | 57 | $1.17B | +$460M | -$160M | +$299M | ALXO, OLMA, DSGN, VERV, DYN | Restatement | 8/17/2021, 04:22 PM |
| Q1 2021 | 53 | $1.02B | +$396M | -$309M | +$86.9M | ALXO, OLMA, DSGN, DYN, TIL | 13F-HR | 5/17/2021, 04:23 PM |
| Q4 2020 | 58 | $1.15B | +$426M | -$400M | +$25.9M | ALXO, OLMA, NKTX, FMTX, TGTX | 13F-HR | 2/16/2021, 04:36 PM |
| Q3 2020 | 46 | $781M | +$541M | -$257M | +$283M | ALXO, KROS, NKTX, FMTX, GBT | Restatement | 11/17/2020, 03:14 PM |
| Q2 2020 | 46 | $500M | +$418M | -$199M | +$219M | FMTX, RETA, CLDX, RNA, RPTX | 13F-HR | 8/14/2020, 12:23 PM |
| Q1 2020 | 40 | $260M | +$154M | -$193M | -$39.8M | ABBV, SRPT, MYOK, MRNA, ASND | 13F-HR | 5/15/2020, 11:32 AM |
| Q4 2019 | 38 | $353M | $0 | $0 | MRTX, SRPT, ASND, AMRN, APLS | 13F-HR | 2/14/2020, 09:27 AM |